Showing results (221-230 of 243) with videos related to
Sort By:
Pageof 25
Bioorganic & Medicinal Chemistry Letters|October 1, 2011
2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinaseMartin J Walsh, Kyle R Brimacombe, Henrike Veith, et al.ACS Pharmacology & Translational Science|May 18, 2023
Quantitative Bioactivity Signatures of Dietary Supplements and Natural ProductsAdam Yasgar, Danielle Bougie, Richard T Eastman, et al.Science Translational Medicine|March 17, 2012
Structure-guided design of a high-affinity platelet integrin αIIbβ3 receptor antagonist that disrupts Mg²⁺ binding to the MIDASJieqing Zhu, Won-Seok Choi, Joshua G McCoy, et al.Chest|April 22, 2017
IVIg for Treatment of Severe Refractory Heparin-Induced ThrombocytopeniaAnand Padmanabhan, Curtis G Jones, Shannon M Pechauer, et al.Journal of Medicinal Chemistry|July 12, 2011
Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenaseVictor Kenyon, Ganesha Rai, Ajit Jadhav, et al.Hemasphere|October 9, 2024
Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53-deficient myeloma cellsRomane Durand, Céline Bellanger, Géraldine Descamps, et al.The Journal of Clinical Investigation|December 23, 2015
A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formationRudy E Fuentes, Sergei Zaitsev, Hyun Sook Ahn, et al.Bioorganic & Medicinal Chemistry Letters|January 3, 2015
Structure activity relationships of human galactokinase inhibitorsLi Liu, Manshu Tang, Martin J Walsh, et al.EMBO Molecular Medicine|April 20, 2021
Myeloid-resident neuropilin-1 promotes choroidal neovascularization while mitigating inflammationElisabeth M M A Andriessen, François Binet, Frédérik Fournier, et al.Nature Biotechnology|February 24, 2021
Biological activity-based modeling identifies antiviral leads against SARS-CoV-2Ruili Huang, Miao Xu, Hu Zhu, et al.Pageof 25